Can brain scans predict developmental disorders? new study seeks answers
NCT ID NCT06367920
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at brain MRI scans and genetic information from 2000 children (healthy and with developmental delays) to create computer models that can predict developmental disorders. The goal is to find patterns in brain structure and genes that explain these conditions. No new treatments are being tested—this is about improving understanding and diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better tools for early detection of developmental disorders in children using brain scans and genetics.
- What could go wrong
- This is a retrospective study that only looks at existing data. It does not test any treatment, so it may not directly help patients. The models may not be accurate enough for real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHA Bundang Medical Center, CHA University
RECRUITINGSeongnam-si, Gyeonggi-do, 463-712, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test